
November 2023 Neurology Recall: Topics in Stroke
Neurology® Podcast
00:00
The Benefits and Risks of Systemic Thrombolysis in Patients on DOACs
This chapter explores a study on the benefits and risks of using systemic thrombolysis in patients receiving Direct Oral Anticoagulants (DOACs) for stroke treatment. The findings show that patients on DOACs experience similar benefits from thrombolysis without an increased risk of death or disability. The speakers discuss the potential need to update the contraindication of recent DOAC ingestion for thrombolytic therapy based on this data.
Transcript
Play full episode